Panacea Biotec Secures Major UNICEF Vaccine Supply Deal
Panacea Biotec announces it has secured a significant supply contract with UNICEF for bivalent oral polio vaccines valued at USD 35.65 million. The agreement, spanning from 2026 to 2030, involves supplying bOPV in various vial sizes to meet UNICEF's global vaccination requirements.
- Country:
- India
Panacea Biotec announced on Friday that it has secured a significant long-term supply order from UNICEF, valued at USD 35.65 million, for bivalent oral polio vaccines.
According to a regulatory filing, the company received a letter of award from UNICEF, confirming a long-term agreement to supply bOPV starting from April 1, 2026, to March 31, 2030.
The contract encompasses the supply of bOPV in 10 and 20 vial presentations to meet UNICEF's needs as specified in future orders.
ALSO READ
-
Sudan Shelter Drone Strike Reportedly Kills a Boy and Injures 12 Children
-
Syria’s Returning Children Need Schools, Care and Safe Water to Rebuild Lives
-
Lebanon’s Children Face Hunger, Lost Schooling and Work as Families Reach the Brink
-
UNICEF Praises Jordan’s Progress for Children as Funding Cuts Threaten Vital Services
-
Somalia Faces Deepening Hunger as Flood Threat Puts Lives and Farms at Risk
Google News